OncoZenge extends payment deadline for remaining SEK 10.1 million private placement proceeds

• OncoZenge extended the payment deadline for about SEK 10.1 million of remaining proceeds in a directed share issue to Sichuan Yangtian Bio-Pharmaceutical.
• Payment was due by July 31, 2026; the deadline moved to Aug. 7, 2026.
• The investor cited an expired SAFE currency exchange certificate as the cause; renewal is in progress.
• OncoZenge expects payment by the new deadline; it will update the market once funds are received and the issue is registered.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oncozenge AB published the original content used to generate this news brief on July 31, 2026, and is solely responsible for the information contained therein.